Discover
BFRI
Biofrontera Inc.
1.19
90 x 1.18
16 x 1.19
bid
ask
-
0.02
1.44%
01:32 PM
timesize
| Ytd | 109.23% | |
| 1y | 30.05% |
1.18
day range
1.24
0.56
52 week range
1.27
| Open | 1.22 | Prev Close | 1.21 | Low | 1.18 | High | 1.24 | Mkt Cap | 15.24M |
| Vol | 159.39K | Avg Vol | 325.25K | EPS | -1.07 | P/E | -1.11 | Forward P/E | -1.17 |
| Beta | 0.78 | Short Ratio | 0.08 | Inst. Own | 20.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.06 | 200-d Avg | 0.94 | 1yr Est | 11.50 |
| Income Statement | |||
| Total Revenue | 10.08M | ||
| Revenues (USD) | 10.08M | ||
| Cost of Revenue | 2.12M | ||
| Gross Profit | 7.97M | ||
| Operating Expenses | 12.29M | ||
| Research and Development Expense | 900.00K | ||
| Selling, General and Administrative Expense | 11.00M | ||
| Operating Income | -4.32M | ||
| Interest Expense | 125.00K | ||
| Net Income | -4.75M | ||
| Net Income Common Stock | -4.75M | ||
| Net Income Common Stock (USD) | -4.75M | ||
| Consolidated Income | -4.75M | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -4.63M | ||
| Earning Before Interest & Taxes (USD) | -4.63M | ||
| Weighted Average Shares | 11.68M | ||
| Weighted Average Shares Diluted | 11.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.32M | ||
| Cash and Equivalents (USD) | 6.32M | ||
| Investments | 9.00K | ||
| Investments Current | 9.00K | ||
| Trade and Non-Trade Receivables | 3.88M | ||
| Current Assets | 13.16M | ||
| Property, Plant & Equipment Net | 5.07M | ||
| Total Assets | 24.79M | ||
| Debt Current | 506.00K | ||
| Total Debt | 7.72M | ||
| Current Liabilities | 10.92M | ||
| Debt Non-Current | 7.22M | ||
| Total Liabilities | 18.72M | ||
| Accumulated Retained Earnings (Deficit) | -132.70M | ||
| Shareholders Equity | 6.07M | ||
| Shareholders Equity (USD) | 6.07M | ||
| Assets Non-Current | 11.63M | ||
| Total Debt (USD) | 7.72M | ||
| Goodwill and Intangible Assets | 2.61M | ||
| Inventory | 4.82M | ||
| Liabilities Non-Current | 7.79M | ||
| Trade and Non-Trade Payables | 4.95M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 187.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -75.00K | ||
| Capital Expenditure | -5.00K | ||
| Net Cash Flow from Investing | -5.00K | ||
| Net Cash Flow from Operations | -70.00K | ||
| Share Based Compensation | 342.00K | ||